KS

Kamal Singh

Active Director Director DIN 09374322
DIN 09374322 First appointment Oct 2021 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Kamal Singh

Data last updated:

Kamal Singh is a Director at Doqtec Pharmaceuticals Private Limited (since 2021). The company operates in Food And Beverages. Doqtec Pharmaceuticals Private Limited reported revenue of ₹96.8 Lakh (FY 2025).

DIN 09374322
Primary Designation Director
Industry Food And Beverages
First Appointment 25 Oct 2021
Oldest Company Age 5 yrs
Largest company Doqtec Pharmaceuticals Private Limited · ₹96.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 20212021₹96.8 Lakh (FY 2025)Active

Board colleagues of Kamal Singh

Directorship timeline

Open interactive timeline →
Doqtec Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kamal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamal Singh

Kamal Singh currently holds 1 directorship: Doqtec Pharmaceuticals Private Limited (Director, since 25 Oct 2021, revenue ₹96.8 Lakh (FY 2025)).

Kamal Singh was first appointed on 25 Oct 2021 as Director at Doqtec Pharmaceuticals Private Limited.

The current boards of Kamal Singh's companies include Anu Verma (Doqtec Pharmaceuticals Private Limited), Naveen Sharma (Doqtec Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available